机构：[1]Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China临床科室肿瘤内科河北医科大学第四医院[2]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院
第一作者机构：[1]Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China[2]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714)：
Shi Jian,Liu Jiayin,Duan Xiaoyang,et al.First-line apatinib plus chemotherapy in extensive-stage small-cell lung cancer[J].JOURNAL OF CLINICAL ONCOLOGY.2020,38(15):doi:10.1200/JCO.2020.38.15_suppl.e21104.
APA：
Shi, Jian,Liu, Jiayin,Duan, Xiaoyang,Huang, Guanglei,Wang, Lixing&Zhao, Yan.(2020).First-line apatinib plus chemotherapy in extensive-stage small-cell lung cancer.JOURNAL OF CLINICAL ONCOLOGY,38,(15)
MLA：
Shi, Jian,et al."First-line apatinib plus chemotherapy in extensive-stage small-cell lung cancer".JOURNAL OF CLINICAL ONCOLOGY 38..15(2020)
医学